Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events

Immune checkpoint inhibitors (ICIs) are nowadays widely used in clinical oncology treatment, and significantly improve the prognosis of cancer patients. However, overactivation of T cells and related signaling pathways caused by ICIs can also induce immune‐related adverse effects (irAEs). Renal immu...

Full description

Bibliographic Details
Main Authors:	Ke Zheng, Wei Qiu, Hanping Wang, Xiaoyan Si, Xiaotong Zhang, Li Zhang, Xuemei Li
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	Thoracic Cancer
Subjects:	Acute kidney injury acute tubulointerstitial nephritis immune checkpoint inhibitors immune‐related adverse events
Online Access:	https://doi.org/10.1111/1759-7714.13405

Similar Items

Clinical Diagnosis and Treatment Recommendation of Immune-related Adverse Renal Events Related to Immune Checkpoint Inhibitor
by: Wei QIU, et al.
Published: (2019-10-01)

Immune-related adverse kidney events by immune checkpoint inhibitors; a narrative review on current studies
by: Tella Sadighpour, et al.
Published: (2021-05-01)

Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report
by: Kenta Tominaga, et al.
Published: (2023-03-01)

Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
by: Busra Isik, et al.
Published: (2021-04-01)

Acute Kidney Injury Induced by Immune Checkpoint Inhibitors
by: Ruixue Tian, et al.
Published: (2022-04-01)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
by: Junling Zhuang, et al.
Published: (2020-03-01)

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
by: Junling ZHUANG, et al.
Published: (2019-10-01)

Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates
by: Shailbala Singh, et al.
Published: (2022-12-01)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events
by: Peng Song, et al.
Published: (2020-08-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
by: Yue LI, et al.
Published: (2019-10-01)

Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports
by: Pasquale Esposito, et al.
Published: (2023-10-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system
by: Yue Li, et al.
Published: (2020-04-01)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
by: Jiaxin Zhou, et al.
Published: (2020-01-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Jiaxin ZHOU, et al.
Published: (2019-10-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors
by: Lian DUAN, et al.
Published: (2019-10-01)

Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor–Induced Kidney Injury
by: Ala Abudayyeh, et al.
Published: (2022-10-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
by: Xiaoyan Si, et al.
Published: (2020-03-01)

Rheumatic Immune-related Adverse Events and Treatment of Immune Checkpoint Inhibitors
by: ZHANG Xue, et al.
Published: (2020-11-01)

Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor—A Report of 3 Cases
by: Sandra M. Herrmann, et al.
Published: (2020-09-01)

Recommendation of Diagnosis and Management for the Infections Related to Immune Checkpoint Inhibitors
by: Minya LU, et al.
Published: (2019-10-01)

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections
by: Minya Lu, et al.
Published: (2020-03-01)

Recent Advance in Biomarkers for Predicting Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors
by: LI Ying, et al.
Published: (2021-04-01)

IMMUNE CHECKPOINT INHIBITORS AND RHEUMATIC ADVERSE EVENTS
by: Ioana Cretu, et al.
Published: (2018-12-01)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
by: Linyang Gan, et al.
Published: (2023-03-01)

Immunopathological basis of immune-related adverse events induced by immune checkpoint blockade therapy
by: Terufumi Kubo, et al.
Published: (2021-09-01)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
by: Lian Duan, et al.
Published: (2020-04-01)

Immune-related adverse events of immune checkpoint inhibitors: a review
by: Qinan Yin, et al.
Published: (2023-05-01)

Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
by: Anca Bobircă, et al.
Published: (2021-06-01)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
by: Lingli Luo, et al.
Published: (2023-04-01)

Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review
by: Marion Allouchery, et al.
Published: (2022-02-01)

Immune checkpoint inhibitors and acute kidney injury
by: Ping Zhou, et al.
Published: (2024-02-01)

Clinical Observation of Adverse Events of Immune Checkpoint Inhibitors in 20 Advanced Tumor Patients and Literature Reviews
by: WANG Xue, et al.
Published: (2020-06-01)

Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients
by: Peng Song, et al.
Published: (2020-09-01)

Advances in Predictive Research of Immune Checkpoint Inhibitors-related  Adverse Events
by: Jing ZHANG, et al.
Published: (2023-10-01)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
by: Rilan Bai, et al.
Published: (2021-11-01)

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy
by: Xiaowei Liu, et al.
Published: (2020-03-01)

Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
by: Iñigo Les, et al.
Published: (2023-03-01)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
by: Caroline Hana, et al.
Published: (2023-03-01)

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
by: Xiaoxiang Zhou, et al.
Published: (2020-04-01)